布西珠單抗

{{Infobox drug
| type = mab
| image =
| width =
| alt =
| caption =

| mab_type = scFv
| source = zu
| target = （VEGF-A）

| pronounce =
| tradename = Beovu
| Drugs.com =
| MedlinePlus = a620001
| DailyMedID = Brolucizumab
| pregnancy_AU = D
| pregnancy_AU_comment =
| pregnancy_category=
| routes_of_administration =
| class =
| ATC_prefix = S01
| ATC_suffix = LA06
| ATC_supplemental =

| legal_AU = S4
| legal_AU_comment =
| legal_BR =
| legal_BR_comment =
| legal_CA = Rx-only
| legal_CA_comment = / Schedule D
| legal_DE =
| legal_DE_comment =
| legal_NZ =
| legal_NZ_comment =
| legal_UK = POM
| legal_UK_comment =
| legal_US = Rx-only
| legal_US_comment = 。

最常見的副作用包括視力下降、白內障（眼睛水晶體混濁）、結膜出血及玻璃體飛蚊症（視野中出現漂浮黑點）。

參考文獻